Trastuzumab and beyond: New possibilities for the treatment of HER2-positive breast cancer.

Oncology (Williston Park, N.Y.)

Volumn 20, Issue 14, 2006, Pages

  Morris, Shannon R ^a   Carey, Lisa A ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; TRASTUZUMAB;

BREAST TUMOR; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; IMMUNOLOGY; METABOLISM; REVIEW; UPREGULATION;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; RECEPTOR, ERBB-2; UP-REGULATION;

EID: 33847616363     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)